NASDAQ$IXHL
Incannex Healthcare Inc · Q2 2025 earnings
Q2 2025 earnings ·
Briefing
IXHL Q2 2025 — $20.0M revenue
As a result, the financial statements included in this report reflect (i) the historical operating results of Incannex. Incannex Healthcare Inc reported Q2 2025 results. Net income of $5.9M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $20.0M.
- Net income: $5.9M.
- Operating income: $5K.
Headline financials
Revenue & EPS history
Incannex Healthcare Inc · Revenue · Quarterly
$12K
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 5 quarterly earnings reports · overlaid with Q2 2025
-0.9%
Avg return
Earnings day
-3.8%
Avg return
5 days after
-12.2%
Avg return
30 days after
33%
2 / 6 earnings
Positive
+11.8%
Q2 2024
Best reaction
-11.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +1.8% | -5.1% | -1.8% | |
| Q1 2026 | -1.4% | -6.7% | +18.5% | |
| Q2 2025 | -0.9% | -9.8% | -58.8% | |
| Q1 2025 | -11.7% | -18.9% | -29.8% | |
| Q3 2024 | -5.2% | -16.5% | +8.5% | |
| Q2 2024 | +11.8% | +34.4% | -9.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro